News for Greenbrook TMS Inc. (GBOKF)

NeuroStar, a Silver Sponsor at CTMSS, will also present two posters as part of the Company's ongoing commitment to clinical innovation and excellence MALVERN.

MALVERN, Pa., June 02, 2025 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ:STIM), a vertically integrated, commercial stage, medical technology and healthcare company with a strategic vision of transforming the lives

New national awareness day will foster greater understanding of transcranial magnetic stimulation (TMS) treatment The company will celebrate on social media, sh

MALVERN, Pa., May 06, 2025 (GLOBE NEWSWIRE) -- Neuronetics, Inc., ( STIM) (the ”œCompany” or ”œNeuronetics”) a vertically integrated, commercial stage,

**media[581340]**

**media[578950]**

MALVERN, Pa., March 04, 2025 (GLOBE NEWSWIRE) -- Neuronetics, Inc. ( STIM) (the ”œCompany” or ”œNeuronetics”) a vertically integrated, commercial stage,

**media[556688]**

MALVERN, Pa., March 03, 2025 (GLOBE NEWSWIRE) -- Neuronetics, Inc. ( STIM), a commercial stage medical technology company focused on designing, developing, an

**media[556115]**

**media[535348]**

MALVERN, Pa., Feb. 07, 2025 (GLOBE NEWSWIRE) -- Neuronetics, Inc. ( STIM) (the ”œCompany”) today announced that it has priced its previously announced unde

MALVERN, Pa., Feb. 06, 2025 (GLOBE NEWSWIRE) -- Neuronetics, Inc. ( STIM) (the ”œCompany”) today announced that it has commenced an underwritten public off

**media[534588]**

**media[527254]**

Preliminary unaudited fourth quarter and full year revenue 2024 was $22.1 and $74.5, respectivelyClosed acquisition of Greenbrook TMS effective as of December 9

**media[496077]**

**media[493966]**

MALVERN, Pa., Dec. 16, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ:STIM) (the